The store will not work correctly when cookies are disabled.
4-but-2-enoyl-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287731
PubChem CID: 76312948
Max Phase: Preclinical
Molecular Formula: C21H24O3
Molecular Weight: 324.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C=C/C(=O)C1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2
Standard InChI: InChI=1S/C21H24O3/c1-5-8-16(22)19-18(17-14(3)11-13(2)12-15(17)4)20(23)24-21(19)9-6-7-10-21/h5,8,11-12H,6-7,9-10H2,1-4H3/b8-5+
Standard InChI Key: YARQGUWCDRRZAI-VMPITWQZSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
35.0840 -11.9596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8378 -11.6428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7694 -10.8281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9734 -10.6413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5499 -11.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1674 -12.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1663 -12.9577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8743 -13.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5840 -12.9572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5811 -12.1345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8725 -11.7293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8701 -10.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4582 -13.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2923 -13.3647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2875 -11.7232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0581 -11.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0808 -10.6687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2995 -10.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6461 -10.4172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2953 -12.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0785 -13.5579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1124 -12.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5299 -13.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3470 -13.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.42 | Molecular Weight (Monoisotopic): 324.1725 | AlogP: 4.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.37 | Molecular Species: ┄ | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.93 | CX LogD: 5.93 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.61 | Np Likeness Score: 0.52 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |